Cargando…
Breast-cancer detection using blood-based infrared molecular fingerprints
BACKGROUND: Breast cancer screening is currently predominantly based on mammography, tainted with the occurrence of both false positivity and false negativity, urging for innovative strategies, as effective detection of early-stage breast cancer bears the potential to reduce mortality. Here we repor...
Autores principales: | Kepesidis, Kosmas V., Bozic-Iven, Masa, Huber, Marinus, Abdel-Aziz, Nashwa, Kullab, Sharif, Abdelwarith, Ahmed, Al Diab, Abdulrahman, Al Ghamdi, Mohammed, Hilal, Muath Abu, Bahadoor, Mohun R. K., Sharma, Abhishake, Dabouz, Farida, Arafah, Maria, Azzeer, Abdallah M., Krausz, Ferenc, Alsaleh, Khalid, Zigman, Mihaela, Nabholtz, Jean-Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638519/ https://www.ncbi.nlm.nih.gov/pubmed/34856945 http://dx.doi.org/10.1186/s12885-021-09017-7 |
Ejemplares similares
-
Stability of person-specific blood-based infrared molecular fingerprints opens up prospects for health monitoring
por: Huber, Marinus, et al.
Publicado: (2021) -
Response to Induction Neoadjuvant Hormonal Therapy Using Upfront 21-Gene Breast Recurrence Score Assay—Results From the SAFIA Phase III Trial
por: AlSaleh, Khalid, et al.
Publicado: (2021) -
Limits and
Prospects of Molecular Fingerprinting for
Phenotyping Biological Systems Revealed through In Silico Modeling
por: Eissa, Tarek, et al.
Publicado: (2023) -
Neoadjuvant endocrine therapy with or without palbociclib in low-risk patients: a phase III randomized double-blind SAFIA trial
por: Alsaleh, K., et al.
Publicado: (2023) -
Molecular Origin of Blood‐Based Infrared Spectroscopic Fingerprints
por: Voronina, Liudmila, et al.
Publicado: (2021)